Regen BioPharma Inc (RGBP) EBIT Margin (2015 - 2025)
Regen BioPharma (RGBP) posted EBIT Margin of -933.93% for fiscal Q1 2026 (quarter ended Dec 31, 2025), down 830.01 percentage points from -103.92% a year earlier and down 726.65 percentage points from the prior quarter.
Regen BioPharma Inc (RGBP) EBIT Margin (2015 - 2025) Analysis & Trends
For the trailing twelve months through Dec 31, 2025, EBIT Margin at Regen BioPharma was -350.35%, down 199.93 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it came in at -143.11%, up 33.26 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of +47.18 percentage points (FY2020 to FY2025).
- In prior fiscal years, Regen BioPharma's EBIT Margin was -176.37% in FY2024 (+114.02 pp), -290.39% in FY2023 (-146.20 pp), -144.20% in FY2022 (-26.92 pp) and -117.28% in FY2021 (+73.01 pp).
- The fiscal Q1 2026 figure stands as the lowest quarterly EBIT Margin in data going back to fiscal Q4 2015.
- On a year-over-year basis, EBIT Margin increased in two of the last eight quarters, with an average year-over-year change of -102.13 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was fiscal Q1 2024, with a gain of 577.47 percentage points; the weakest was fiscal Q1 2026, with a drop of 830.01 percentage points.
- According to Business Quant data, EBIT Margin for the three prior fiscal quarters was -207.28% (Q4 2025), -69.00% (Q3 2025) and -191.91% (Q2 2025).
Peer Comparison
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -933.93% |
| Sep 30, 2025 | -207.28% |
| Jun 30, 2025 | -69.00% |
| Mar 31, 2025 | -191.91% |
| Dec 31, 2024 | -103.92% |
| Sep 30, 2024 | -143.86% |
| Jun 30, 2024 | -182.79% |
| Mar 31, 2024 | -171.12% |
| Dec 31, 2023 | -207.88% |
| Sep 30, 2023 | -99.53% |
| Jun 30, 2023 | -144.17% |
| Mar 31, 2023 | -133.48% |
| Dec 31, 2022 | -785.35% |
| Sep 30, 2022 | -164.71% |
| Jun 30, 2022 | -100.33% |
| Mar 31, 2022 | -131.05% |
| Dec 31, 2021 | -180.18% |
| Sep 30, 2021 | -212.39% |
| Jun 30, 2021 | -75.03% |
| Mar 31, 2021 | -47.30% |
Regen BioPharma Inc EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=RGBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "RGBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=RGBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();